The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops.
Baqar S, Bonavia A, Louis Bourgeois A, Campo JJ, Clifford A, Hanevik K, Hasso-Agopsowicz M, Hausdorff W, Kaminski R, MacLennan CA, Mantis N, Martin LB, Omore R, Pasetti M, Pavlinac P, Phalipon A, Poly F, Porter C, Ramasamy MN, Rogawski McQuade ET, Sztein MB, Walker R.
Baqar S, et al. Among authors: martin lb.
Vaccine. 2024 Mar 7;42(7):1445-1453. doi: 10.1016/j.vaccine.2023.11.045. Epub 2023 Nov 30.
Vaccine. 2024.
PMID: 38036392
Free PMC article.
The remaining four workshops examined the assessment of vaccine impact on acute and long-term morbidity. These included discussions on the nature and severity of intestinal inflammation; cellular immunity and immunological memory in ETEC and Shigella infections; clinical a …
The remaining four workshops examined the assessment of vaccine impact on acute and long-term morbidity. These included discussions o …